Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CTi Biopharma Corp (NASDAQ:CTIC)

During the Trading Day
1.53 -0.05 / -3.16%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.53 0.00 / 0.00%
 
Volume: 8.9K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$285.4M

Company Description

CTI BioPharma Corp. operates as a biopharmaceutical company, which is focused on the acquisition, development, and commercialization of less toxic and more effective ways to treat cancer. Its products include Pixuvri, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Contact Information

CTI BioPharma Corp.
3101 Western Avenue
Seattle Washington 98121
P:(206) 282-7100
Investor Relations:
(206) 272-4343

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

James A. BiancoPresident, Chief Executive Officer & Director
Lou A. BiancoExecutive Vice President-Finance & Administration
Jack W. SingerDirector & Chief Scientific Officer
Bruce J. SeeleyChief Commercial Officer & Executive VP
Matthew J. PlunkettExecutive Vice President-Corporate Development